Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors

Details for Australian Patent Application No. 2002236131 (hide)

Owner Pfizer Products Inc.

Inventors Mylari, Banavara Lakshman

Agent Spruson & Ferguson

Pub. Number AU-B-2002236131

PCT Pub. Number WO2002/087584

Priority 60/287,524 30.04.01 US

Filing date 25 February 2002

Wipo publication date 11 November 2002

Acceptance publication date 14 April 2005

International Classifications

A61K 031/50 - Pyridazines

Event Publications

17 April 2003 Application Open to Public Inspection

  Published as AU-B-2002236131

14 April 2005 Application Accepted

  Published as AU-B-2002236131

11 August 2005 Standard Patent Sealed

18 October 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002236132-MODIFIED RELEASE ORAL PHARMACEUTICAL COMPOSITION

2002236130-SKIN TREATING DEVICE COMPRISING A PROTECTED RADIATION EXIT OPENING